TAO Synergies Inc.
- Market Cap (Float-Adj) (Float-adjusted market cap computed by the low-float screener — matches the screener row. May differ from the standard cap (price × all shares outstanding) reported elsewhere.)
- $28.9M
- Price
- $3.86
- % Change (Daily % change from the live per-ticker quote feed.)
- +4.89%
- Volume
- 358.7K
About
TAO Synergies Inc. operates as a biopharmaceutical company currently in the clinical development stage. It is dedicated to advancing a bryostatin-1 therapeutic platform, specifically designed to combat Alzheimer's and various other neurodegenerative and cognitive disorders. Beyond its drug development efforts, the firm is also diversifying its treasury strategy, with a new approach centered on the management of digital assets, primarily focusing on the acquisition and 'staking' of TAO cryptocurrency.
Quick stats
Shares outstanding7.5M
Computed float7.3M
Float / shares97.8%
Key info
SectorTechnology
IndustrySoftware - Application
CIK (Central Index Key — the unique ID the SEC assigns to every filer. Use it to look up the company's filings on EDGAR.)0001571934
Websitehttps://www.taosynergies.com
AI Summary
AI-generated1/3
minorbullishoperations update
TAO Synergies Appoints Bittensor Investor and Author Mark Jeffrey as Advisor
TAO Synergies appointed Mark Jeffrey, a partner at Stillcore Capital and host of the Hash Rate podcast, as an advisor to support its expansion into decentralized AI.
Jeffrey will advise on Bittensor ecosystem strategy, subnet evaluation, and application development as the company moves beyond holding assets to active investment and building.
Executive Chairman Josh Silverman highlighted Jeffrey's deep expertise in subnet economics as critical for the company's next phase of growth.